ADVFN US – Market Content Editor
-

Antelope Enterprise Approves 1-for-6 Reverse Stock Split Effective March 4
Antelope Enterprise Holdings (NASDAQ:AEHL) said on March 3, 2026 that its board has authorized a 1-for-6 reverse stock split of the company’s Class A ordinary shares. As a result of the consolidation, the number of shares outstanding will decrease from 7,344,694 to approximately 1,224,116. The company’s shares will continue trading on the Nasdaq Capital Market…
-

Propanc Biopharma Spotlights PRP as Potential Breakthrough for Metastatic Solid Tumors
Propanc Biopharma (NASDAQ:PPCB) is drawing attention to the therapeutic promise of its lead candidate, PRP, an investigational proenzyme treatment aimed at tackling metastatic cancer arising from solid tumors—particularly aggressive, poorly differentiated forms associated with poor patient outcomes. Pancreatic cancer remains among the most lethal malignancies, with a five-year survival rate of just 13%, compared to…
-

Mobix Labs Secures Production Order for Tomahawk Missile Components
Mobix Labs, Inc. (NASDAQ:MOBX) said Tuesday it has received a production purchase order for components used in the U.S. Navy’s Tomahawk cruise missile program, underscoring its role as a supplier to active defense platforms. The order covers high-reliability filtering components designed to reduce electromagnetic interference within the missile’s onboard electronic systems. According to the company,…
-

Ziff Davis to Divest Ookla and Downdetector to Accenture in $1.2 Billion Deal
Ziff Davis (NASDAQ:ZD) has reached an agreement to sell its Connectivity business to Accenture in a cash transaction valued at $1.2 billion, marking another step in the company’s multi-year portfolio reshaping strategy. The divested unit includes well-known assets such as Ookla’s Speedtest platform and outage-monitoring service Downdetector, along with Ekahau and RootMetrics. Following the sale,…
-

Theravance Biopharma to Restructure After Late-Stage Ampreloxetine Setback
Theravance Biopharma (NASDAQ:TBPH) said March 3, 2026 that its Phase 3 CYPRESS study evaluating ampreloxetine in patients with symptomatic neurogenic orthostatic hypotension (nOH) linked to multiple system atrophy did not achieve its primary endpoint, prompting the company to discontinue the program. The biotech firm said it will carry out additional data analyses solely to determine…
-

Gaxos.ai Buys Minority Stake in U.S. Defense Firm to Advance ‘Made in America’ Drone Technology
Gaxos.ai Inc. (NASDAQ:GXAI) is moving into the defense sector with a new strategic investment, marking a shift beyond its core artificial intelligence content offerings. The company said Tuesday it has acquired a 19.99% ownership interest in America First Defense (AFD), a U.S.-based defense technology developer. Financial details of the transaction were not disclosed. America First…
-

Pinterest Surges 10% After $1 Billion Elliott Investment and Expanded Buyback Plan
Pinterest Inc. (NYSE:PINS) shares jumped 10% on Tuesday after the company unveiled a $1 billion strategic investment from Elliott Investment Management and outlined plans to significantly expand its share repurchase efforts. The social media company said it will deploy the proceeds from Elliott’s investment toward a $1 billion accelerated share repurchase (ASR) program. At the…
-

AutoZone Shares Drop After Revenue Miss in Fiscal Q2
AutoZone (NYSE:AZO) shares fell sharply Tuesday after the auto parts retailer reported fiscal second-quarter results that beat earnings expectations but came in slightly short on revenue. The company posted earnings per share of $27.63, ahead of the analyst consensus of $27.17. However, revenue totaled $4.27 billion, missing forecasts of $4.31 billion. Shares declined more than…
-

Viper Energy Slides After $798 Million Secondary Share Sale
Viper Energy (NASDAQ:VNOM) shares fell 3.2% to $46.05 in premarket trading Tuesday after the company priced a large secondary offering valued at roughly $798 million. The Midland, Texas-based mineral and royalty interests owner said late Monday that approximately 17.4 million shares were sold by existing holders, including parent company Diamondback Energy (NASDAQ:FANG), EnCap affiliates and…
-

MongoDB Shares Sink 27% on Soft FY27 Outlook Despite Q4 Beat
MongoDB Inc. (NASDAQ:MDB) shares plunged more than 27% after the company released its fiscal fourth-quarter 2026 results, as a weaker-than-expected outlook overshadowed a solid quarterly performance. For the quarter ended January 31, 2026, the database software provider reported adjusted earnings per share of $1.65, beating the analyst consensus of $1.48 by $0.17. Revenue climbed 27%…